11 June 2019
Machine learning experts who may not have previous experience of working on dementia will have the chance to meet DPUK’s senior researcher at the first in a new series of events for data scientists. They’ll learn about opportunities to apply their skills and make a real impact on developing treatments for dementia.
15 April 2019
One in three people born today will develop dementia in their lifetime: it's the biggest health challenge of our generation. With one million people predicted to have dementia by 2025 in the UK, and a current cost of £26bn a year to the UK economy, there is huge financial and societal impact, yet we’re still without treatment.
8 February 2019
DPUK has launched Great Minds, an innovative new register of volunteers for clinical trials who bring rich data from their previous health studies to help clear the deadlock in development of treatments for dementia.
24 January 2019
Cognetivity is announced as the ninth industry partner for Dementias Platform UK. It joins forces with DPUK’s existing partnership of eight other industry companies and ten universities working to develop new resources to power cohort-based research into dementia.
14 December 2018
Are you working in the Data Portal? Have you made an application for DPUK cohort data? We want to hear about your experiences so we can best focus our Data Portal development work. If you have particular requirements or needs for your research, we want to hear about them, so please get in touch.
24 October 2018
Data scientists from many different backgrounds combined their expertise to take on dementia in an unusual format for disease research: a three-day datathon. The intensive research event saw teams come together to work on data that is now available in the DPUK Data Portal.
31 May 2018
Following recent feedback, DPUK has updated its publications policy. Anyone who uses DPUK data or resources, or whose work is funded through the platform, is invited to comment.
4 May 2018
Body-worn sensors used by people with mild Alzheimer’s to assess walking could offer a cost-effective way to detect the disease early and monitor its progression.